Polycystic Ovary Syndrome and the Metabolic Syndrome Long-Term Risks

    January 2008 in “ Humana Press eBooks ”
    Eva Dahlgren, Per Olof Janson
    Studysummary This article reviews the relationship between polycystic ovary syndrome and various health issues but provides no new clinical findings; it emphasizes the need for continued research and lifestyle interventions.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on link.springer.com →
    Discuss this study in the Community →

    Research cited in this study 5

    1. Finasteride Versus Cyproterone Acetate-Estrogen Regimens in the Treatment of Hirsutism International journal of gynaecology and obstetrics · 2004
    2. Polycystic Ovary Syndrome and Cardiovascular Disease: A Premature Association? Endocrine Reviews · 2003
    3. Topical Eflornithine: Efficacy in Reducing Unwanted Facial Hair Growth in Women American journal of clinical dermatology · 2001
    4. Usefulness of a 12-Month Treatment with Finasteride in Idiopathic and Polycystic Ovary Syndrome-Associated Hirsutism PubMed · 1999
    5. Gonadotrophin-Releasing Hormone Agonist Therapy for Hirsutism Is as Effective as High Dose Cyproterone Acetate but Results in a Longer Remission Human reproduction · 1997

    Related research 1

    1. Polycystic Ovary Syndrome and the Metabolic Syndrome Long-Term Risks Humana Press eBooks · 2008